VanEck ETF Trust VanEck Consumer Discretionary TruSector ETF TRUD 深 沪
等待开盘 10-01 09:30:00 美东时间
26.0319
-0.134
-0.51%
华盛通- 最 高26.0319
- 今 开25.925
- 成交量 444股
- 最 低 25.925
- 昨 收 26.1656
- 总市值 52.06万
- 52周最高 26.49
- 市盈率 静 --
- 换手率 2.22%
- 52周最低 24.5571
- 委 比 0.00%
- 总股本 2.00万
- 历史最高 26.49
- 量 比 0.02
- 振 幅 0.41%
- 历史最低 24.5571
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Merck's Keytruda Gets Green Light For New Head And Neck Cancer Use, European Approval Decision Due This Year
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted two positive opinions for
09-19 18:48
Eli Lilly's Olomorasib + KEYTRUDA Combo Secures FDA Breakthrough Therapy Designation For KRAS G12C NSCLC With High PD-L1
The Breakthrough Therapy designation for olomorasib is based on data from the Phase 1/2 LOXO-RAS-20001 trial and Phase 3 SUNRAY-01 trialUpdated efficacy and safety data for olomorasib will be presented at the IASLC 2025
09-04 18:50
VanEck Targets Nvidia, Microsoft Weight Caps With TruSector ETFs For Tech, Consumer Sectors
VanEck has new ETFs that aim to minimize tracking error by eliminating artificial limits on leading holdings.
08-26 21:17
HCW Biologics Shares Soar On Breakthrough Second-Generation Cancer Immunotherapy
HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors.
08-26 04:32
